{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:32:32Z","timestamp":1761845552043,"version":"3.41.2"},"reference-count":201,"publisher":"Elsevier","isbn-type":[{"type":"print","value":"9780323913133"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/b978-0-323-91313-3.00012-x","type":"book-chapter","created":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T06:35:01Z","timestamp":1659162901000},"page":"233-263","source":"Crossref","is-referenced-by-count":2,"title":["The gut microbiome in chronic kidney disease"],"prefix":"10.1016","author":[{"given":"Ana","family":"Merino-Ribas","sequence":"first","affiliation":[]},{"given":"Carolina F.F.A.","family":"Costa","sequence":"additional","affiliation":[]},{"given":"Maria","family":"Azevedo","sequence":"additional","affiliation":[]},{"given":"In\u00eas","family":"Alencastre","sequence":"additional","affiliation":[]},{"given":"Manuel","family":"Pestana","sequence":"additional","affiliation":[]},{"given":"Ricardo","family":"Araujo","sequence":"additional","affiliation":[]},{"given":"Benedita","family":"Sampaio-Maia","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"year":"2016","series-title":"Understanding kidney diseases","author":"Rayner","key":"10.1016\/B978-0-323-91313-3.00012-X_bb0010"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0015","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","author":"National Kidney","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0020","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","article-title":"Chronic kidney disease","volume":"389","author":"Webster","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0025","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3390\/toxins10070287","article-title":"Gut microbiota and cardiovascular uremic toxicities","volume":"10","author":"Velasquez","year":"2018","journal-title":"Toxins (Basel)"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0030","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0735-1097(00)00804-4","article-title":"Myocardial infarction redefined\u2014a consensus document of The Joint European Society of Cardiology\/American College of Cardiology Committee for the redefinition of myocardial infarction","volume":"36","author":"Alpert","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0035","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0140-6736(13)60687-X","article-title":"Chronic kidney disease: global dimension and perspectives","volume":"382","author":"Jha","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0040","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis","volume":"375","author":"Matsushita","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0045","doi-asserted-by":"crossref","first-page":"489","DOI":"10.2215\/CJN.02550310","article-title":"Factors affecting employment at initiation of dialysis","volume":"6","author":"Muehrer","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"Suppl 3","key":"10.1016\/B978-0-323-91313-3.00012-X_bb0050","doi-asserted-by":"crossref","first-page":"iii32-8","DOI":"10.1093\/ndt\/gfs113","article-title":"The impact of CKD identification in large countries: the burden of illness","volume":"27","author":"Jha","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0055","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000360184","article-title":"Awareness of kidney disease among US adults: findings from the 2011 behavioral risk factor surveillance system","volume":"39","author":"Li","year":"2014","journal-title":"Am J Nephrol"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0060","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1053\/j.ajkd.2010.08.022","article-title":"CKD awareness and blood pressure control in the primary care hypertensive population","volume":"57","author":"Ravera","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb1016","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nature11234","article-title":"Structure, function and diversity of the healthy human microbiome","volume":"486","year":"2012","journal-title":"Nature"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0065","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/QCO.0000000000000196","article-title":"The intestinal microbiome and health","volume":"28","author":"Tuddenham","year":"2015","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0070","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/nature09944","article-title":"Enterotypes of the human gut microbiome","volume":"473","author":"Arumugam","year":"2011","journal-title":"Nature"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0075","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/microorganisms7010014","article-title":"What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases","volume":"7","author":"Rinninella","year":"2019","journal-title":"Microorganisms"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0080","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/ni.2608","article-title":"Control of pathogens and pathobionts by the gut microbiota","volume":"14","author":"Kamada","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0085","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/mi.2016.114","article-title":"Microbiota metabolite short-chain fatty acid acetate promotes intestinal IgA response to microbiota which is mediated by GPR43","volume":"10","author":"Wu","year":"2017","journal-title":"Mucosal Immunol"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0090","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.3389\/fmicb.2018.01835","article-title":"The human gut microbiome\u2014a potential controller of wellness and disease","volume":"9","author":"Kho","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0095","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4161\/gmic.27129","article-title":"Dysbiosis in the inflamed intestine: chance favors the prepared microbe","volume":"5","author":"Winter","year":"2014","journal-title":"Gut Microbes"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0100","doi-asserted-by":"crossref","first-page":"17707","DOI":"10.1038\/s41598-017-18014-5","article-title":"A gut pathobiont synergizes with the microbiota to instigate inflammatory disease marked by immunoreactivity against other symbionts but not itself","volume":"7","author":"Gomes-Neto","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0105","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/nyas.14107","article-title":"Gut microbiome and its role in obesity and insulin resistance","volume":"1461","author":"Lee","year":"2020","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0110","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/4441022a","article-title":"Microbial ecology: human gut microbes associated with obesity","volume":"444","author":"Ley","year":"2006","journal-title":"Nature"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0115","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/17474124.2019.1543023","article-title":"Obesity, diabetes, and the gut microbiome: an updated review","volume":"13","author":"Singer-Englar","year":"2019","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0120","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/bs.aambs.2016.06.002","article-title":"The role of the gut microbiome on chronic kidney disease","volume":"96","author":"Sampaio-Maia","year":"2016","journal-title":"Adv Appl Microbiol"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0125","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.phrs.2018.02.011","article-title":"The microbiome in chronic kidney disease patients undergoing hemodialysis and peritoneal dialysis","volume":"130","author":"Sim\u00f5es-Silva","year":"2018","journal-title":"Pharmacol Res"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0130","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12882-019-1668-4","article-title":"High-throughput sequencing analysis of intestinal flora changes in ESRD and CKD patients","volume":"21","author":"Hu","year":"2020","journal-title":"BMC Nephrol"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0135","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41581-019-0172-1","article-title":"Intestinal microbiome and fitness in kidney disease","volume":"15","author":"Meijers","year":"2019","journal-title":"Nat Rev Nephrol"},{"issue":"Suppl 4","key":"10.1016\/B978-0-323-91313-3.00012-X_bb0140","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/nep.13452","article-title":"Diet, gut microbiome and indoxyl sulphate in chronic kidney disease patients","volume":"23","author":"Yang","year":"2018","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0145","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000360010","article-title":"Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD","volume":"39","author":"Wong","year":"2014","journal-title":"Am J Nephrol"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0150","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/gut.32.7.754","article-title":"Impaired intestinal barrier function measured by differently sized polyethylene glycols in patients with chronic renal failure","volume":"32","author":"Magnusson","year":"1991","journal-title":"Gut"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0155","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13588","article-title":"Interplay between gut microbiota, bone health and vascular calcification in chronic kidney disease","volume":"51","author":"Rodrigues","year":"2021","journal-title":"Eur J Clin Investig"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0160","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1093\/ndt\/gfr624","article-title":"Disintegration of colonic epithelial tight junction in uremia: a likely cause of CKD-associated inflammation","volume":"27","author":"Vaziri","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0165","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1042\/CS20190171","article-title":"Quantitative reduction in short-chain fatty acids, especially butyrate, contributes to the progression of chronic kidney disease","volume":"133","author":"Wang","year":"2019","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0170","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/19490976.2015.1134082","article-title":"Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism","volume":"7","author":"Morrison","year":"2016","journal-title":"Gut Microbes"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0175","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1038\/s41598-017-02989-2","article-title":"Alteration of the gut microbiota in Chinese population with chronic kidney disease","volume":"7","author":"Jiang","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0180","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1007\/s10482-016-0737-y","article-title":"A reduction in the butyrate producing species Roseburia spp. and Faecalibacterium prausnitzii is associated with chronic kidney disease progression","volume":"109","author":"Jiang","year":"2016","journal-title":"Antonie Van Leeuwenhoek"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0185","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/advances\/nmz028","article-title":"Gastrointestinal microbiota in patients with chronic kidney disease: a systematic review","volume":"10","author":"Chung","year":"2019","journal-title":"Adv Nutr"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134311","article-title":"Gut-microbiota-metabolite axis in early renal function decline","volume":"10","author":"Barrios","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0195","doi-asserted-by":"crossref","DOI":"10.1177\/0300060520926033","article-title":"Intestinal flora alterations in patients with early chronic kidney disease: a case-control study among the Han population in southwestern China","volume":"48","author":"Hu","year":"2020","journal-title":"J Int Med Res"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0200","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1440-1797.2012.01647.x","article-title":"Gut bacterial translocation is associated with microinflammation in end-stage renal disease patients","volume":"17","author":"Wang","year":"2012","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0205","article-title":"Altered gut microbiota and microbial biomarkers associated with chronic kidney disease","volume":"8","author":"Lun","year":"2019","journal-title":"Microbiology"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0210","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12967-019-1969-1","article-title":"Dysbiosis of the gut microbiome is associated with CKD5 and correlated with clinical indices of the disease: a case-controlled study","volume":"17","author":"Li","year":"2019","journal-title":"J Transl Med"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0215","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1177\/1535370218818175","article-title":"Fecal microbiota analysis of polycystic kidney disease patients according to renal function: a pilot study","volume":"244","author":"Yacoub","year":"2019","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0220","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/00325481.2020.1744335","article-title":"Characterizing the gut microbiota in patients with chronic kidney disease","volume":"132","author":"Hu","year":"2020","journal-title":"Postgrad Med"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0225","doi-asserted-by":"crossref","first-page":"420","DOI":"10.7150\/ijbs.37421","article-title":"Gut microbiota as diagnostic tools for mirroring disease progression and circulating nephrotoxin levels in chronic kidney disease: discovery and validation study","volume":"16","author":"Wu","year":"2020","journal-title":"Int J Biol Sci"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0230","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000071292","article-title":"Patients with chronic renal failure have abnormal small intestinal motility and a high prevalence of small intestinal bacterial overgrowth","volume":"67","author":"Strid","year":"2003","journal-title":"Digestion"},{"year":"2006","series-title":"Handbook of dialysis","author":"Daugirdas","key":"10.1016\/B978-0-323-91313-3.00012-X_bb0235"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0240","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00467-016-3392-7","article-title":"Gut microbiome and kidney disease: a bidirectional relationship","volume":"32","author":"Al Khodor","year":"2017","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0245","article-title":"Dialysis: a review of the mechanisms underlying complications in the management of chronic renal failure","volume":"9","author":"Vadakedath","year":"2017","journal-title":"Cureus"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0250","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1525-139X.2011.00925.x","article-title":"Vascular incompetence in dialysis patients\u2014protein-bound uremic toxins and endothelial dysfunction","volume":"24","author":"Jourde-Chiche","year":"2011","journal-title":"Semin Dial"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0255","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrneph.2011.194","article-title":"Infectious complications in dialysis\u2014epidemiology and outcomes","volume":"8","author":"Li","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0260","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0272-6386(04)01078-9","article-title":"Dialysis catheter-related bacteremia: treatment and prophylaxis","volume":"44","author":"Allon","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0265","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.2215\/CJN.01590309","article-title":"Staphylococcus aureus infections in hemodialysis: what a nephrologist should know","volume":"4","author":"Vandecasteele","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0270","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/ki.2012.440","article-title":"The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease","volume":"83","author":"Anders","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0275","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3389\/fphar.2020.00258","article-title":"Hypertension is associated with intestinal microbiota dysbiosis and inflammation in a Brazilian population","volume":"11","author":"Silveira-Nunes","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0280","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature11450","article-title":"A metagenome-wide association study of gut microbiota in type 2 diabetes","volume":"490","author":"Wang","year":"2012","journal-title":"Nature"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0285","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1128\/CMR.00063-15","article-title":"The microbiome, systemic immune function, and allotransplantation","volume":"29","author":"Nellore","year":"2015","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178228","article-title":"Impact of maintenance immunosuppressive therapy on the fecal microbiome of renal transplant recipients: comparison between an everolimus-and a standard tacrolimusbased regimen","volume":"12","author":"Zaza","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0295","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3390\/nu12020381","article-title":"Role of dietary nutrients in the modulation of gut microbiota: a narrative review","volume":"12","author":"Yang","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0300","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/ndt\/gfg004","article-title":"Mesenteric ischaemia in haemodialysis patients: a case\/control study","volume":"18","author":"Bassilios","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0305","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2215\/CJN.04610510","article-title":"Circulating endotoxemia: a novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease","volume":"6","author":"McIntyre","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0310","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1159\/000189334","article-title":"Inhibition of the accumulation of uremic toxins in the blood and their precursors in the feces after oral administration of Lebenin\u00ae, a lactic acid bacteria preparation, to uremic patients undergoing hemodialysis?","volume":"74","author":"Hida","year":"1996","journal-title":"Nephron"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0315","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ki.2012.345","article-title":"Chronic kidney disease alters intestinal microbial flora","volume":"83","author":"Vaziri","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0320","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-15650-9","article-title":"Structural and functional differences in gut microbiome composition in patients undergoing haemodialysis or peritoneal dialysis","volume":"7","author":"Stadlbauer","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0325","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s40168-016-0195-9","article-title":"Intestinal microbiota in pediatric patients with end stage renal disease: a Midwest Pediatric Nephrology Consortium study","volume":"4","author":"Crespo-Salgado","year":"2016","journal-title":"Microbiome"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/microorganisms8122040","article-title":"Comparative gut microbiome differences between ferric citrate and calcium carbonate phosphate binders in patients with end-stage kidney disease","volume":"8","author":"Wu","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0335","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1093\/ndt\/gfx029","article-title":"Microbiome perturbation by oral vancomycin reduces plasma concentration of two gut-derived uremic solutes, indoxyl sulfate and p-cresyl sulfate, in end-stage renal disease","volume":"32","author":"Nazzal","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0340","series-title":"Handbook of dialysis","article-title":"Physiology of peritoneal dialysis","author":"Daugirdas","year":"2006"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0345","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/434608","article-title":"Peritoneal dialysis drop-out: causes and prevention strategies","volume":"2011","author":"Chaudhary","year":"2011","journal-title":"Int J Nephrol"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0350","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1128\/AEM.05605-11","article-title":"Real-time PCR analysis of the intestinal microbiotas in peritoneal dialysis patients","volume":"78","author":"Wang","year":"2012","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0355","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.579386","article-title":"The effects of hemodialysis and peritoneal dialysis on the gut microbiota of end-stage renal disease patients, and the relationship between gut microbiota and patient prognoses","volume":"11","author":"Luo","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0360","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1177\/0896860820976983","article-title":"Clinical characteristics associated with the properties of gut microbiota in peritoneal dialysis patients","volume":"41","author":"Jiang","year":"2021","journal-title":"Perit Dial Int"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0365","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1053\/j.ajkd.2019.01.031","article-title":"Management of kidney transplant recipients by general nephrologists: core curriculum 2019","volume":"73","author":"Voora","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0370","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.carj.2013.06.002","article-title":"Renal transplant complications: diagnostic and therapeutic role of radiology","volume":"65","author":"Inci","year":"2014","journal-title":"Can Assoc Radiol J"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0375","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/ckj\/sfaa271","article-title":"The ERA-EDTA registry annual report 2018: a summary","volume":"14","author":"Kramer","year":"2021","journal-title":"Clin Kidney J"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0380","first-page":"587","article-title":"Surgical complications after kidney transplantation","volume":"14","author":"Haberal","year":"2016","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0385","first-page":"3330","article-title":"Organ transplantation and gut microbiota: current reviews and future challenges","volume":"10","author":"Xiao","year":"2018","journal-title":"Am J Transl Res"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0390","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.biopha.2017.02.114","article-title":"Gut microbiota and renal transplant outcome","volume":"90","author":"Ardalan","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0395","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/nep.13670","article-title":"Transplant associated infections-the role of the gastrointestinal microbiota and potential therapeutic options","volume":"25","author":"Chan","year":"2020","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0400","first-page":"1401","article-title":"Gut microbiota in renal transplant recipients, patients with chronic kidney disease and healthy subjects","volume":"38","author":"Guirong","year":"2018","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0405","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3390\/jcm9020386","article-title":"Characteristics and dysbiosis of the gut microbiome in renal transplant recipients","volume":"9","author":"Swarte","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0410","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.3390\/microorganisms8111724","article-title":"Impact of the post-transplant period and lifestyle diseases on human gut microbiota in kidney graft recipients","volume":"8","author":"Souai","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0415","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/nep.13853","article-title":"Characteristics of the gastrointestinal microbiota in paired live kidney donors and recipients","volume":"26","author":"Chan","year":"2021","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0420","first-page":"697","article-title":"Gut microbial community structure and complications after kidney transplantation: a pilot study","volume":"98","author":"Lee","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0425","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227373","article-title":"Gut microbiota composition alterations are associated with the onset of diabetes in kidney transplant recipients","volume":"15","author":"Lecronier","year":"2020","journal-title":"PLoS ONE"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0430","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1124\/dmd.118.084772","article-title":"Commensal gut bacteria convert the immunosuppressant tacrolimus to less potent metabolites","volume":"47","author":"Guo","year":"2019","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0435","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14260","article-title":"Gut microbiota profiles and fecal beta-glucuronidase activity in kidney transplant recipients with and without post-transplant diarrhea","volume":"35","author":"Zhang","year":"2021","journal-title":"Clin Transpl"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0440","article-title":"Gut microbiota and tacrolimus dosing in kidney transplantation","volume":"10","author":"Lee","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0445","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1007\/s00253-020-11069-x","article-title":"Gut microbiota alterations associated with antibody-mediated rejection after kidney transplantation","volume":"105","author":"Wang","year":"2021","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0450","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12967-018-1756-4","article-title":"Microbiome-metabolome reveals the contribution of gut-kidney axis on kidney disease","volume":"17","author":"Chen","year":"2019","journal-title":"J Transl Med"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0455","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3390\/toxins12040245","article-title":"Gut-derived metabolites and their role in immune dysfunction in chronic kidney disease","volume":"12","author":"Glorieux","year":"2020","journal-title":"Toxins (Basel)"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0460","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3390\/toxins13020142","article-title":"Uremic toxins in the progression of chronic kidney disease and cardiovascular disease: mechanisms and therapeutic targets","volume":"13","author":"Lim","year":"2021","journal-title":"Toxins (Basel)"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0465","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1681\/ASN.2013121283","article-title":"The cardiovascular effect of the uremic solute indole-3 acetic acid","volume":"26","author":"Dou","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0470","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.bbrc.2020.02.141","article-title":"Effects of the oral adsorbent AST-120 on fecal p-cresol and indole levels and on the gut microbiota composition","volume":"525","author":"Sato","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119450","article-title":"Effect of uremic state in intestine through a co-culture in vitro intestinal epithelial model","volume":"584","author":"Garcia","year":"2020","journal-title":"Int J Pharm"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0480","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1681\/ASN.2010121220","article-title":"Colonic contribution to uremic solutes","volume":"22","author":"Aronov","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0485","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3390\/toxins12010058","article-title":"Molecular and cellular mechanisms that induce arterial calcification by indoxyl sulfate and p-cresyl sulfate","volume":"12","author":"Opdebeeck","year":"2020","journal-title":"Toxins"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0490","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1080\/10408398.2020.1761771","article-title":"Intestinal microbiota alterations in chronic kidney disease and the influence of dietary components","volume":"61","author":"Ondrussek-Sekac","year":"2021","journal-title":"Crit Rev Food Sci Nutr"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0495","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/femsec\/fiy125","article-title":"Identification of phenol- and p-cresol-producing intestinal bacteria by using media supplemented with tyrosine and its metabolites","volume":"94","author":"Saito","year":"2018","journal-title":"FEMS Microbiol Ecol"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0500","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1038\/ki.2009.402","article-title":"Uremic toxins originating from colonic microbial metabolism","author":"Evenepoel","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0505","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.3390\/ijms21061986","article-title":"Isolation and quantification of uremic toxin precursor-generating gut bacteria in chronic kidney disease patients","volume":"21","author":"Gryp","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0510","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1136\/gutjnl-2018-317561","article-title":"Gut microbiota dynamics and uraemic toxins: one size does not fit all","volume":"68","author":"Joossens","year":"2019","journal-title":"Gut"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0515","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1016\/j.cell.2021.03.024","article-title":"The long-term genetic stability and individual specificity of the human gut microbiome","volume":"184","author":"Chen","year":"2021","journal-title":"Cell"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0520","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1038\/s41467-018-05470-4","article-title":"Microbial tryptophan catabolites in health and disease","volume":"9","author":"Roager","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0525","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.chom.2016.10.021","article-title":"Modulation of a circulating uremic solute via rational genetic manipulation of the gut microbiota","volume":"20","author":"Devlin","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0530","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1574-6976.2009.00204.x","article-title":"Indole as an intercellular signal in microbial communities","volume":"34","author":"Lee","year":"2010","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0535","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1136\/gutjnl-2019-319766","article-title":"Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents","volume":"69","author":"Wang","year":"2020","journal-title":"Gut"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0540","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/ajcn\/nqz337","article-title":"Inulin-type fructan intervention restricts the increase in gut microbiome-generated indole in patients with peritoneal dialysis: a randomized crossover study","volume":"111","author":"Li","year":"2020","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0545","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1253\/circj.CJ-18-0468","article-title":"Gut microbiome and plasma microbiome-related metabolites in patients with decompensated and compensated heart failure","volume":"83","author":"Hayashi","year":"2018","journal-title":"Circ J"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0550","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.kint.2020.01.028","article-title":"Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease","volume":"97","author":"Gryp","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0555","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s00018-020-03645-1","article-title":"Gut microbiota-derived tryptophan metabolism mediates renal fibrosis by aryl hydrocarbon receptor signaling activation","volume":"78","author":"Liu","year":"2021","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0560","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1016\/j.celrep.2017.05.077","article-title":"The TMAO-producing enzyme flavin-containing monooxygenase 3 regulates obesity and the beiging of white adipose tissue","volume":"19","author":"Schugar","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0565","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/s41598-017-01387-y","article-title":"Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patients","volume":"7","author":"Xu","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0570","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02481-14","article-title":"Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide","volume":"6","author":"Romano","year":"2015","journal-title":"MBio"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0575","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1053\/j.jrn.2010.05.002","article-title":"Indoxyl sulfate is a nephro-vascular toxin","volume":"20","author":"Niwa","year":"2010","journal-title":"J Ren Nutr"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0580","first-page":"96","article-title":"Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis","volume":"124","author":"Niwa","year":"1997","journal-title":"J Lab Clin Med"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0585","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.2215\/CJN.03980609","article-title":"Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients","volume":"4","author":"Barreto","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0590","article-title":"Meta-analysis of the associations of p-cresyl sulfate (PCS) and indoxyl sulfate (IS) with cardiovascular events and all-cause mortality in patients with chronic renal failure","volume":"10","author":"Lin","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0595","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/ndt\/gfn522","article-title":"Effective removal of protein-bound uraemic solutes by different convective strategies: a prospective trial","volume":"24","author":"Meert","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0600","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/ndt\/gfl584","article-title":"P-cresylsulphate, the main in vivo metabolite of p-cresol, activates leucocyte free radical production","volume":"22","author":"Schepers","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0605","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3390\/toxins10060226","article-title":"Uremic toxin clearance and cardiovascular toxicities","volume":"10","author":"Mair","year":"2018","journal-title":"Toxins (Basel)"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0610","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1681\/ASN.2013060597","article-title":"Prominent accumulation in hemodialysis patients of solutes normally cleared by tubular secretion","volume":"25","author":"Sirich","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0615","first-page":"179","article-title":"Indoxyl sulfate and progression of renal failure: effects of a low-protein diet and oral sorbent on indoxyl sulfate production in uremic rats and undialyzed uremic patients","volume":"23","author":"Niwa","year":"1997","journal-title":"Miner Electrolyte Metab"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0620","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/j.1538-7836.2007.02540.x","article-title":"The uremic solute indoxyl sulfate induces oxidative stress in endothelial cells","volume":"5","author":"Dou","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0625","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/01.tp.0000436906.48802.c4","article-title":"Uremic toxin development in living kidney donors: a longitudinal study","volume":"97","author":"Rossi","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0630","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s40620-017-0381-2","article-title":"Long term variation of serum levels of uremic toxins in patients treated by post-dilution high volume on-line hemodiafiltration in comparison to standard low-flux bicarbonate dialysis: results from the Redert study","volume":"30","author":"Panichi","year":"2017","journal-title":"J Nephrol"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0635","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1053\/j.ajkd.2015.08.029","article-title":"Future avenues to decrease uremic toxin concentration","volume":"67","author":"Vanholder","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0640","first-page":"6707","article-title":"Estimation of removed uremic toxin indoxyl sulphate during hemodialysis by using optical data of the spent dialysate","volume":"2013","author":"Holmar","year":"2013","journal-title":"Annu Int Conf IEEE Eng Med Biol Soc"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0645","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1053\/j.ajkd.2004.04.033","article-title":"Removal of the protein-bound solute p-cresol by convective transport: a randomized crossover study","volume":"44","author":"Bammens","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0650","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/ndt\/gfp437","article-title":"Protein-bound uraemic toxin removal in haemodialysis and post-dilution haemodiafiltration","volume":"25","author":"Krieter","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0655","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1093\/ndt\/gfr056","article-title":"Warning: the unfortunate end of p-cresol as a uraemic toxin","volume":"26","author":"Vanholder","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0660","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1681\/ASN.2011121175","article-title":"Normal and pathologic concentrations of uremic toxins","volume":"23","author":"Duranton","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0665","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1177\/1535370219826526","article-title":"The role of chronic kidney disease-associated dysbiosis in cardiovascular disease","volume":"244","author":"Bryniarski","year":"2019","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0670","doi-asserted-by":"crossref","DOI":"10.4161\/21688370.2014.977176","article-title":"Claudin-2 as a mediator of leaky gut barrier during intestinal inflammation","volume":"3","author":"Luettig","year":"2015","journal-title":"Tissue Barriers"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0675","first-page":"608","article-title":"Pathology of gastrointestinal tract in chronic hemodialysis patients: an autopsy study of 78 cases","volume":"80","author":"Vaziri","year":"1985","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0680","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1159\/000343886","article-title":"Uremic plasma impairs barrier function and depletes the tight junction protein constituents of intestinal epithelium","volume":"36","author":"Vaziri","year":"2012","journal-title":"Am J Nephrol"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0685","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000345969","article-title":"Role of urea in intestinal barrier dysfunction and disruption of epithelial tight junction in chronic kidney disease","volume":"37","author":"Vaziri","year":"2013","journal-title":"Am J Nephrol"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0690","doi-asserted-by":"crossref","first-page":"bvz039","DOI":"10.1210\/jendso\/bvz039","article-title":"Intestinal barrier dysfunction, LPS translocation, and disease development","volume":"4","author":"Ghosh","year":"2020","journal-title":"J Endocr Soc"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0695","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2014an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0700","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.amjcard.2016.07.071","article-title":"Coronary plaque characterization assessed by optical coherence tomography and plasma trimethylamine-N-oxide levels in patients with coronary artery disease","volume":"118","author":"Fu","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0705","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/ncomms2266","article-title":"Symptomatic atherosclerosis is associated with an altered gut metagenome","volume":"3","author":"Karlsson","year":"2012","journal-title":"Nat Commun"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0710","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1161\/CIRCULATIONAHA.105.579979","article-title":"Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease","volume":"113","author":"Ott","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0715","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41467-017-00900-1","article-title":"The gut microbiome in atherosclerotic cardiovascular disease","volume":"8","author":"Jie","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0720","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3390\/toxins13040252","article-title":"The impact of CKD on uremic toxins and gut microbiota","volume":"13","author":"Rysz","year":"2021","journal-title":"Toxins (Basel)"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0725","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003698","article-title":"Gut microbiota promote angiotensin II-induced arterial hypertension and vascular dysfunction","volume":"5","author":"Karbach","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0730","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1161\/HYPERTENSIONAHA.114.03469","article-title":"Effect of probiotics on blood pressure: a systematic review and meta-analysis of randomized, controlled trials","volume":"64","author":"Khalesi","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0735","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/s41440-018-0203-5","article-title":"Gut microbiota and hypertension","volume":"42","author":"Oyama","year":"2019","journal-title":"Hypertens Res"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0740","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1161\/CIRCRESAHA.116.309006","article-title":"Hypertension-linked pathophysiological alterations in the gut","volume":"120","author":"Santisteban","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0745","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/sj.ki.5000115","article-title":"Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients","volume":"69","author":"Bammens","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0750","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.2215\/CJN.02940509","article-title":"p-Cresyl sulfate and indoxyl sulfate in hemodialysis patients","volume":"4","author":"Meijers","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0755","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/ndt\/gfq580","article-title":"p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease","volume":"26","author":"Wu","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0760","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1681\/ASN.2014030288","article-title":"Gut bacteria products prevent AKI induced by ischemia-reperfusion","volume":"26","author":"Andrade-Oliveira","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0765","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cmet.2011.02.018","article-title":"The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon","volume":"13","author":"Donohoe","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0770","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046589","article-title":"Microbial regulation of glucose metabolism and cell-cycle progression in mammalian colonocytes","volume":"7","author":"Donohoe","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0775","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.imbio.2015.06.004","article-title":"Lactate and short chain fatty acids produced by microbial fermentation downregulate proinflammatory responses in intestinal epithelial cells and myeloid cells","volume":"220","author":"Iraporda","year":"2015","journal-title":"Immunobiology"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0780","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1053\/j.ajkd.2017.06.017","article-title":"Deoxycholic acid, a metabolite of circulating bile acids, and coronary artery vascular calcification in CKD","volume":"71","author":"Jovanovich","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0785","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1681\/ASN.2014101047","article-title":"Uremic toxicity of advanced glycation end products in CKD","volume":"27","author":"Stinghen","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0790","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/s41581-018-0018-2","article-title":"The gut microbiota and the brain-gut-kidney axis in hypertension and chronic kidney disease HHS public access","volume":"14","author":"Yang","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0795","doi-asserted-by":"crossref","DOI":"10.3390\/nu11030496","article-title":"Dietary components that may influence the disturbed gut microbiota in chronic kidney disease","volume":"11","author":"Mafra","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0800","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/sdi.12348","article-title":"Dietary restrictions in dialysis patients: is there anything left to eat?","volume":"28","author":"Kalantar-Zadeh","year":"2015","journal-title":"Semin Dial"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0805","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.3390\/nu11092149","article-title":"Dietary fiber and gut microbiota in renal diets","volume":"11","author":"Camerotto","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0810","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/ejcn.2014.237","article-title":"Dietary fiber effects in chronic kidney disease: a systematic review and meta-analysis of controlled feeding trials","volume":"69","author":"Chiavaroli","year":"2015","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0815","first-page":"598","article-title":"Dietary fiber intake is associated with chronic kidney disease (CKD) progression and cardiovascular risk, but not protein nutritional status, in adults with CKD","volume":"26","author":"Lu","year":"2017","journal-title":"Asia Pac J Clin Nutr"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0820","doi-asserted-by":"crossref","first-page":"982","DOI":"10.2215\/CJN.12491211","article-title":"The production of p-cresol sulfate and indoxyl sulfate in vegetarians versus omnivores","volume":"7","author":"Patel","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0825","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.nut.2017.08.015","article-title":"Red meat intake in chronic kidney disease patients: two sides of the coin","volume":"46","author":"Mafra","year":"2018","journal-title":"Nutrition"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0830","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000346628","article-title":"Very low protein diet reduces indoxyl sulfate levels in chronic kidney disease","volume":"35","author":"Marzocco","year":"2013","journal-title":"Blood Purif"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0835","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1053\/j.jrn.2017.11.007","article-title":"Does low-protein diet influence the uremic toxin serum levels from the gut microbiota in nondialysis chronic kidney disease patients?","volume":"28","author":"Black","year":"2018","journal-title":"J Ren Nutr"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0840","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/jcsm.12264","article-title":"Low-protein diet for conservative management of chronic kidney disease: a systematic review and meta-analysis of controlled trials","volume":"9","author":"Rhee","year":"2018","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0845","doi-asserted-by":"crossref","DOI":"10.3390\/nu12071931","article-title":"Plant-dominant low-protein diet for conservative management of chronic kidney disease","volume":"12","author":"Kalantar-Zadeh","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0850","doi-asserted-by":"crossref","first-page":"890","DOI":"10.3389\/fmicb.2018.00890","article-title":"Shifts on gut microbiota associated to Mediterranean diet adherence and specific dietary intakes on general adult population","volume":"9","author":"Garcia-Mantrana","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0855","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1017\/S0007114517001593","article-title":"Adherence to the Mediterranean diet is associated with the gut microbiota pattern and gastrointestinal characteristics in an adult population","volume":"117","author":"Mitsou","year":"2017","journal-title":"Br J Nutr"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0870","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s10787-012-0126-8","article-title":"A review of the pharmacobiotic regulation of gastrointestinal inflammation by probiotics, commensal bacteria and prebiotics","volume":"20","author":"Vitetta","year":"2012","journal-title":"Inflammopharmacology"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0875","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/ndt\/gfp414","article-title":"p-Cresyl sulfate serum concentrations in haemodialysis patients are reduced by the prebiotic oligofructose-enriched inulin","volume":"25","author":"Meijers","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0880","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/ajcn\/63.3.392","article-title":"Supplementation with gum Arabic fiber increases fecal nitrogen excretion and lowers serum urea nitrogen concentration in chronic renal failure patients consuming a low-protein diet","volume":"63","author":"Bliss","year":"1996","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0885","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.ekir.2020.05.023","article-title":"A pilot study on the effect of prebiotic on host-microbial co-metabolism in peritoneal dialysis patients","volume":"5","author":"Gao","year":"2020","journal-title":"Kidney Int Rep"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0890","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1007\/s11255-019-02291-2","article-title":"The gut microbiota and its relationship with chronic kidney disease","volume":"51","author":"Plata","year":"2019","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0895","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3390\/microorganisms7080228","article-title":"Gut dysbiosis and the intestinal microbiome: Streptococcus thermophilus a key probiotic for reducing uremia","volume":"7","author":"Vitetta","year":"2019","journal-title":"Microorganisms"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0900","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/mnfr.201200714","article-title":"Uremia and chronic kidney disease: the role of the gut microflora and therapies with pro- and prebiotics","volume":"57","author":"Vitetta","year":"2013","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0905","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s12325-010-0059-9","article-title":"Pilot study of probiotic dietary supplementation for promoting healthy kidney function in patients with chronic kidney disease","volume":"27","author":"Ranganathan","year":"2010","journal-title":"Adv Ther"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0910","first-page":"92","article-title":"Biomodulation of the toxic and nutritional effects of small bowel bacterial overgrowth in end-stage kidney disease using freeze-dried lactobacillus acidophilus","volume":"22","author":"Simenhoff","year":"1996","journal-title":"Miner Electrolyte Metab"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0915","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.kint.2016.09.040","article-title":"Probiotic supplementation in diabetic hemodialysis patients has beneficial metabolic effects","volume":"91","author":"Soleimani","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0920","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3920\/BM2014.0088","article-title":"The effect of probiotics on serum levels of cytokine and endotoxin in peritoneal dialysis patients: a randomised, double-blind, placebo-controlled trial","volume":"6","author":"Wang","year":"2015","journal-title":"Benefic Microbes"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0925","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1053\/j.jrn.2020.04.008","article-title":"Effects of probiotics on malnutrition and health-related quality of life in patients undergoing peritoneal dialysis: a randomized controlled trial","volume":"31","author":"Pan","year":"2021","journal-title":"J Ren Nutr"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0930","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2215\/CJN.05240515","article-title":"Synbiotics easing renal failure by improving gut microbiology (synergy): a randomized trial","volume":"11","author":"Rossi","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0935","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1093\/ndt\/gfq624","article-title":"Effects of synbiotic treatment on serum level of p-cresol in haemodialysis patients: a preliminary study","volume":"26","author":"Nakabayashi","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0940","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.numecd.2014.04.007","article-title":"Effect of short-term synbiotic treatment on plasma p-cresol levels in patients with chronic renal failure: a randomized clinical trial","volume":"24","author":"Guida","year":"2014","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0945","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s40620-018-0516-0","article-title":"Microbiota issue in CKD: how promising are gut-targeted approaches?","volume":"32","author":"Cosola","year":"2019","journal-title":"J Nephrol"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0950","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s40265-019-1064-1","article-title":"Management of hypertension in chronic kidney disease","volume":"79","author":"Pugh","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0955","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1161\/HYPERTENSIONAHA.115.05315","article-title":"Gut microbiota dysbiosis is linked to hypertension","volume":"65","author":"Yang","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0960","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1053\/j.ackd.2010.05.007","article-title":"Antibiotic pharmacokinetic and pharmacodynamic considerations in patients with kidney disease","volume":"17","author":"Eyler","year":"2010","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0965","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/jcpt.12342","article-title":"Adherence with renal dosing recommendations in outpatients undergoing haemodialysis","volume":"41","author":"Kim","year":"2016","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0970","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.coph.2019.09.012","article-title":"Fibrosis and the intestinal microbiome; a focus on chronic liver disease","volume":"49","author":"Beraza","year":"2019","journal-title":"Curr Opin Pharmacol"},{"year":"2019","series-title":"The gut microbiome: Relationships with disease and opportunities for therapy","author":"Durack","key":"10.1016\/B978-0-323-91313-3.00012-X_bb0975"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0980","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/mi.2016.123","article-title":"Pretreatment with antibiotics may enhance the efficacy of fecal microbiota transplantation in ulcerative colitis: a meta-analysis","volume":"10","author":"Keshteli","year":"2017","journal-title":"Mucosal Immunol"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0985","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/MNH.0000000000000565","article-title":"Microbiome modulation to correct uremic toxins and to preserve kidney functions","volume":"29","author":"Caggiano","year":"2020","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0990","first-page":"859","article-title":"Successful therapy of Clostridium difficile infection with fecal microbiota transplantation","volume":"67","author":"Konturek","year":"2016","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb0995","first-page":"e85","article-title":"High mortality risk in chronic kidney disease and end stage kidney disease patients with clostridium difficile infection: a systematic review and meta-analysis","volume":"1","author":"Thongprayoon","year":"2015","journal-title":"J Nat Sci"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb1000","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3390\/toxins12120741","article-title":"Effects of fecal microbiota transplantation on composition in mice with CKD","volume":"12","author":"Barba","year":"2020","journal-title":"Toxins"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb1005","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000453673","article-title":"Effect of AST-120 in chronic kidney disease treatment: still a controversy?","volume":"135","author":"Yamaguchi","year":"2017","journal-title":"Nephron"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb1010","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bbr.2014.07.027","article-title":"Serotonin, tryptophan metabolism and the brain-gut-microbiome axis","volume":"277","author":"O'Mahony","year":"2015","journal-title":"Behav Brain Res"},{"key":"10.1016\/B978-0-323-91313-3.00012-X_bb1015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0237086","article-title":"Renoprotective effects of paramylon, a beta-1,3-D-glucan isolated from Euglena gracilis Z in a rodent model of chronic kidney disease","volume":"15","author":"Nagayama","year":"2020","journal-title":"PLoS ONE"}],"container-title":["Human-Gut Microbiome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B978032391313300012X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B978032391313300012X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T09:06:46Z","timestamp":1754125606000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B978032391313300012X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9780323913133"],"references-count":201,"URL":"https:\/\/doi.org\/10.1016\/b978-0-323-91313-3.00012-x","relation":{},"subject":[],"published":{"date-parts":[[2022]]}}}